Jeff David
About Jeff David
Jeff David is a Cell Therapy Account Manager for the US CAR T Program at Bristol-Myers Squibb, with over three decades of experience in oncology.
Company
Jeff David is currently employed at Bristol-Myers Squibb, a global biopharmaceutical company. In his role, he focuses on the Cell Therapy Account Manager within the US CAR T Program. Additionally, he serves as a Senior Academic Institutional Tumor Specialist in the Immuno-Oncology division based in Ann Arbor, Michigan.
Title
Jeff David holds the title of Cell Therapy Account Manager for the US CAR T Program at Bristol-Myers Squibb. He also operates as a Senior Academic Institutional Tumor Specialist within the company.
Education and Expertise
Jeff David earned a Bachelor of Science (B.S.) in Biology/Biological Sciences from Wayne State University. With over three decades of experience in the oncology field, his expertise is built on a strong educational foundation and substantial professional experience.
Professional Background
Jeff David began his career at GlaxoSmithKline Oncology, where he worked as an Academic Cancer Center Specialist from 1988 to 2020, accumulating 32 years of experience in that capacity. Since January 2020, he has been with Bristol-Myers Squibb, focusing on cell therapy and immuno-oncology.
Experience in Oncology
Jeff David has a vast background in oncology, with significant roles spanning more than three decades. His tenure at GlaxoSmithKline Oncology as an Academic Cancer Center Specialist has equipped him with extensive knowledge and experience, which he now applies in his current positions at Bristol-Myers Squibb.